Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.9M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
7.7M
-
Shares change
-
+4.05M
-
Total reported value, excl. options
-
$44.4M
-
Value change
-
+$25.1M
-
Number of buys
-
22
-
Number of sells
-
-11
-
Price
-
$5.77
Significant Holders of Equillium, Inc. - Common Stock (EQ) as of Q3 2020
37 filings reported holding EQ - Equillium, Inc. - Common Stock as of Q3 2020.
Equillium, Inc. - Common Stock (EQ) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.7M shares
of 60.9M outstanding shares and own 12.64% of the company stock.
Largest 10 shareholders include VICTORY CAPITAL MANAGEMENT INC (2.35M shares), Samsara BioCapital, LLC (1.07M shares), RTW INVESTMENTS, LP (1M shares), FRANKLIN RESOURCES INC (700K shares), FARALLON CAPITAL MANAGEMENT LLC (700K shares), VANGUARD GROUP INC (673K shares), FMR LLC (210K shares), Alyeska Investment Group, L.P. (153K shares), Asymmetry Capital Management, L.P. (144K shares), and Invesco Ltd. (139K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.